Surgery Partners Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Surgery Partners Inc in the second quarter 2026?
Surgery Partners Inc achieved a return on average equity (ROE) of 2.63 % in its second quarter 2026, which is below Surgery Partners Inc 's average return on equity, which stands at 6.46%.

ROE fell compared to the first quarter 2026, despite the net income growth of % from the first quarter 2026.

Within the Healthcare Facilities industry 22 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2043 to 2135.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	-1.74 %	-1.84 %	-2.04 %	0.97 %	-
Y / Y Net Income Change	-33.85 %	-	-	295.31 %	58.1 %
Net Income (TTM) in Millions	82	97	99	23	4
Return On Equity (TTM)	2.63 %	3.1 %	3.14 %	0.74 %	0.14 %
SGRY's Total Ranking	# 2135	# 2043	# 2097	# 0	# 2000
Equity (TTM) in Millions	3,102	3,098	3,131	3,142	3,157
Seq. Equity Change	0.12 %	-1.07 %	-0.34 %	-0.46 %	0.02 %
Seq. Net Income Change	-	-	14.62 %	-43.65 %	-

Back to SGRY Management Effectiveness >> SGRY's 5 Years Annual ROE >> Compare SGRY ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 23
Sector	# 177
Overall	# 2135

Return On Equity Statistics
High	Average	Low
45.66 %	6.46 %	-8.39 %
(Mar 31 2016)		(Jun 30 2019)

SGRY Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	3,131	3,196	3,035	2,941	1,970
Y / Y Equity Change	-2.04 %	5.34 %	3.18 %	49.31 %	123.29 %
Net Income in Millions	99	13	135	87	71
Y / Y Net Income Change	691.2 %	-90.76 %	55.52 %	23.06 %	5338.46 %
Return On Equity	3.16 %	0.39 %	4.46 %	2.96 %	3.59 %

Back to SGRY Management Effectiveness >> SGRY's 5 Years Annual ROE >> Compare SGRY ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 3.16 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SGRY's' Return on Equity at Yahoo Finance
SGRY's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SGRY's Competitors
Subscribers only: Roe for Surgery Partners Inc 's Suppliers
Subscribers only: Return On Equity for SGRY's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Vericel Corporation	6.91 %
The Cooper Companies Inc	6.90 %
Siga Technologies Inc	6.74 %
Merck and Co Inc	6.59 %
Zimmer Biomet Holdings Inc	6.36 %
National Vision Holdings Inc	5.71 %
Conmed Corporation	5.51 %
Pfizer Inc	4.91 %
Privia Health Group Inc	4.23 %
Becton Dickinson And Company	3.79 %
Alkermes Plc	3.72 %
Lifemd Inc	3.47 %
Lifestance Health Group Inc	3.39 %
Revvity Inc	3.27 %
Bio rad Laboratories Inc	3.15 %
Envista Holdings Corporation	3.08 %
Immucell Corporation	2.68 %
Surgery Partners Inc	2.63 %
Mimedx Group Inc	2.61 %
Cormedix Inc	2.18 %
Atricure Inc	2.14 %
Pacira Biosciences inc	2.13 %
Warby Parker Inc	2.06 %
Repligen Corp	1.98 %
Arvinas Inc	1.91 %
Waters Corporation	1.88 %
Omada Health Inc	1.84 %
Radnet Inc	1.42 %
Icu Medical Inc	1.41 %
Biomarin Pharmaceutical Inc	1.18 %

Date modified: 2026-09-08T22:14:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.